Status:
COMPLETED
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. An observational study evaluating the blood glucose control in patients using a modern insulin: NovoRapid®, NovoMix® 30 or Levemir® for treatment of Type 2 diabetes ...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Current treatment with human soluble insulin, insulin NPH or premixed human insulin
- The selection of the subjects will be at the discretion of the individual physician
Exclusion
- Current treatment with insulin aspart, insulin detemir or biphasic insulin aspart 30
- Previous enrolment in this study
- Hypersensitivity to insulin aspart, insulin detemir or biphasic insulin aspart 30 or to any of the excipients.
- Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 6 months and considered to be treated by biphasic insulin aspart 30 or insulin detemir
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
6500 Patients enrolled
Trial Details
Trial ID
NCT00670722
Start Date
January 1 2008
End Date
December 1 2009
Last Update
October 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Prague, Czechia, 16000